Adults

TrialNet Pathway to Prevention T1D

Screening and Monitoring
 
Joslin Diabetes Center, Boston, MA
Yale University, New Haven, CT
Naomi Berrie Diabetes Center, New York, NY
Multiple Other Sites

STOP T1D

Low Dose Antithymocyte Globulin (ATG) to Delay or Prevent Progression to Stage 3 T1D

Naomi Berrie Diabetes Center, New York, NY
Yale University, New Haven, CT
STOP-T1D Trial Website


Recruiting

PREDICT Study

Phenotyping Relatives of persons with Diabetes with CGM and Tests of beta cell function and health

Yale University, New Haven, CT

Predict Website

Recruiting

Immune Function Study

Immune Function and the Progression into Type 1 Diabetes

Remote/Local Lab

Recruiting

PROMISE Study

PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

Icahn School of Medicine at Mount Sinai, New York, NY
Joslin Diabetes Center, Boston, MA

Recruiting

 

T1D Exchange Registry

Remote

Recruiting

  • The safety and scientific validity of a research study is the responsibility of the study investigators and the study sponsor.
  • It is important to evaluate the risks and potential benefits of clinical studies and to talk to your health care provider(s) before participating in a study.